Matinas BioPharma Holdings, Inc. (MTNB) Form S-3 — Jun 16, 2026
Matinas BioPharma Holdings, Inc. has filed a replacement registration statement on Form S-3 to extend the offering period for up to $150 million of securities. This shelf filing allows the company to offer common stock, preferred stock, debt securities, warrants, subscription rights, or units on a delayed or continuous basis. The company intends to use the net proceeds from any future sales for working capital and general corporate purposes.
Key figures
- Stock Price
- 0.75
- Public Float
- 5579577
- Shares Outstanding
- 6406191
- Aggregate Offering Amount
- 150000000
- Public Float Shares
- 6398597
Price after filing
1 day: -1.4%7 days: -9.7%30 days: -52.7%
Close on the filing date to close N calendar days later (from $0.72). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.